The angiographic catheters market size has grown strongly in recent years. It will grow from $1.42 billion in 2025 to $1.55 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to reliance on conventional angiographic catheters, limited imaging technology integration, increasing prevalence of cardiovascular diseases, growth of hospital-based interventional procedures, early adoption of balloon angioplasty.
The angiographic catheters market size is expected to see strong growth in the next few years. It will grow to $2.21 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to development of drug eluting and scoring balloon catheters, integration with mra and ct technologies, rising demand from neurology and oncology interventions, expansion of cardiac and specialty centers, adoption of smart catheter systems with real-time imaging. Major trends in the forecast period include rising adoption of minimally invasive procedures, increasing use of drug eluting and cutting balloon catheters, growth in coronary and endovascular applications, integration of advanced imaging technologies with catheters, focus on patient safety and reduced procedure time.
The increasing number of heart surgeries is expected to propel the growth of the angiographic catheters market going forward. Heart surgery, also referred to as cardiac surgery, includes a wide range of surgical procedures performed on the heart or the great vessels. The number of heart surgeries is rising due to several factors, including an aging population, an increase in cardiovascular diseases, advancements in medical technology, and improved surgical outcomes. Angiographic catheters are utilized in heart surgeries to visualize coronary arteries, allowing for accurate diagnosis and treatment of blockages or abnormalities. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, reflecting a 4% increase from 224.4 per 100,000 in 2023. Therefore, the growing number of heart surgeries is fueling the growth of the angiographic catheters market.
Companies operating in the angiographic catheters market are advancing technologies such as fiber optic realShape (FORS) to enable real-time, high-resolution 3D imaging during catheter navigation, reducing radiation exposure and improving precision in complex vascular procedures. Fiber optic realShape (FORS) technology is an imaging platform that uses light reflected through optical fibers within medical devices to generate real-time, high-resolution 3D visualizations of device shapes inside the body, supporting accurate navigation during minimally invasive procedures. For example, in February 2024, Philips Healthcare, a Netherlands-based health technology company, launched LumiGuide, a light-based, radiation-free catheter guidance system for endovascular aortic procedures. Using FORS technology, LumiGuide produces real-time, high-resolution 3D images of devices within the body, enabling navigation without reliance on X-ray angiography. Key features include enhanced 3D visualization, reduced radiation exposure, immediate orientation feedback, and AI-assisted registration to improve accuracy during complex procedures. Available in select hospitals across Europe and the US, LumiGuide aims to improve patient safety and procedural efficiency.
In October 2023, Cordis Medical Device Co., Ltd., a US-based medical company, acquired MedAlliance Swiss Medical Technology for an undisclosed amount. This acquisition is expected to strengthen Cordis’ ability to accelerate access to advanced technologies, thereby improving patient care in the cardiovascular field. It also aims to enhance Cordis’ portfolio by offering innovative solutions for the treatment of vascular diseases. MedAlliance Swiss Medical Technology is a Switzerland-based developer of angiographic catheters.
Major companies operating in the angiographic catheters market are Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Cook Medical Inc., Teleflex Incorporated, BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Asahi Intecc Co Ltd., AngioDynamics Inc., Biosensors International Group Ltd., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Reva Medical Inc.
North America was the largest region in the angiographic catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angiographic catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the angiographic catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the angiographic catheters market by increasing the cost of imported raw materials and advanced imaging-compatible catheter components. Segments such as drug eluting balloon catheters and cutting balloon catheters are most impacted, particularly in Asia-Pacific regions including China and India, which are major manufacturing hubs. While tariffs increase production costs and supply chain complexity, they also promote local manufacturing initiatives and encourage innovation in domestic catheter designs and imaging-compatible devices.
The angiographic catheters market research report is one of a series of new reports that provides angiographic catheters market statistics, including angiographic catheters industry global market size, regional shares, competitors with a angiographic catheters market share, detailed angiographic catheters market segments, market trends and opportunities, and any further data you may need to thrive in the angiographic catheters industry. This angiographic catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Angiographic catheters are specialized medical tools used in angiography to help diagnose and treat conditions affecting blood vessels. These slender, flexible tubes are inserted into the vascular system to deliver contrast dye, allowing real-time X-ray images (angiograms) of arteries, veins, and heart chambers so doctors can evaluate blockages, aneurysms, or other vascular problems.
The key product types of angiographic catheters include conventional catheters, drug-eluting balloon catheters, cutting balloon catheters, and scoring balloon catheters. Conventional catheters, also referred to as non-coated catheters, represent the standard design for intermittent urinary catheterization. The technologies include X-ray, magnetic resonance angiography (MRA), and computed tomography (CT), and the applications cover coronary, endovascular, neurological, oncology, and other procedures. They are used by end-users such as hospitals, ambulatory surgical centers, cardiac centers, brain centers, specialty clinics, and others.
The angiographic catheters market consists of sales of catheter shafts, tips, lumens, connectors, and balloons. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The angiographic catheters market size is expected to see strong growth in the next few years. It will grow to $2.21 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to development of drug eluting and scoring balloon catheters, integration with mra and ct technologies, rising demand from neurology and oncology interventions, expansion of cardiac and specialty centers, adoption of smart catheter systems with real-time imaging. Major trends in the forecast period include rising adoption of minimally invasive procedures, increasing use of drug eluting and cutting balloon catheters, growth in coronary and endovascular applications, integration of advanced imaging technologies with catheters, focus on patient safety and reduced procedure time.
The increasing number of heart surgeries is expected to propel the growth of the angiographic catheters market going forward. Heart surgery, also referred to as cardiac surgery, includes a wide range of surgical procedures performed on the heart or the great vessels. The number of heart surgeries is rising due to several factors, including an aging population, an increase in cardiovascular diseases, advancements in medical technology, and improved surgical outcomes. Angiographic catheters are utilized in heart surgeries to visualize coronary arteries, allowing for accurate diagnosis and treatment of blockages or abnormalities. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, reflecting a 4% increase from 224.4 per 100,000 in 2023. Therefore, the growing number of heart surgeries is fueling the growth of the angiographic catheters market.
Companies operating in the angiographic catheters market are advancing technologies such as fiber optic realShape (FORS) to enable real-time, high-resolution 3D imaging during catheter navigation, reducing radiation exposure and improving precision in complex vascular procedures. Fiber optic realShape (FORS) technology is an imaging platform that uses light reflected through optical fibers within medical devices to generate real-time, high-resolution 3D visualizations of device shapes inside the body, supporting accurate navigation during minimally invasive procedures. For example, in February 2024, Philips Healthcare, a Netherlands-based health technology company, launched LumiGuide, a light-based, radiation-free catheter guidance system for endovascular aortic procedures. Using FORS technology, LumiGuide produces real-time, high-resolution 3D images of devices within the body, enabling navigation without reliance on X-ray angiography. Key features include enhanced 3D visualization, reduced radiation exposure, immediate orientation feedback, and AI-assisted registration to improve accuracy during complex procedures. Available in select hospitals across Europe and the US, LumiGuide aims to improve patient safety and procedural efficiency.
In October 2023, Cordis Medical Device Co., Ltd., a US-based medical company, acquired MedAlliance Swiss Medical Technology for an undisclosed amount. This acquisition is expected to strengthen Cordis’ ability to accelerate access to advanced technologies, thereby improving patient care in the cardiovascular field. It also aims to enhance Cordis’ portfolio by offering innovative solutions for the treatment of vascular diseases. MedAlliance Swiss Medical Technology is a Switzerland-based developer of angiographic catheters.
Major companies operating in the angiographic catheters market are Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Cook Medical Inc., Teleflex Incorporated, BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Asahi Intecc Co Ltd., AngioDynamics Inc., Biosensors International Group Ltd., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Reva Medical Inc.
North America was the largest region in the angiographic catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angiographic catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the angiographic catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the angiographic catheters market by increasing the cost of imported raw materials and advanced imaging-compatible catheter components. Segments such as drug eluting balloon catheters and cutting balloon catheters are most impacted, particularly in Asia-Pacific regions including China and India, which are major manufacturing hubs. While tariffs increase production costs and supply chain complexity, they also promote local manufacturing initiatives and encourage innovation in domestic catheter designs and imaging-compatible devices.
The angiographic catheters market research report is one of a series of new reports that provides angiographic catheters market statistics, including angiographic catheters industry global market size, regional shares, competitors with a angiographic catheters market share, detailed angiographic catheters market segments, market trends and opportunities, and any further data you may need to thrive in the angiographic catheters industry. This angiographic catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Angiographic catheters are specialized medical tools used in angiography to help diagnose and treat conditions affecting blood vessels. These slender, flexible tubes are inserted into the vascular system to deliver contrast dye, allowing real-time X-ray images (angiograms) of arteries, veins, and heart chambers so doctors can evaluate blockages, aneurysms, or other vascular problems.
The key product types of angiographic catheters include conventional catheters, drug-eluting balloon catheters, cutting balloon catheters, and scoring balloon catheters. Conventional catheters, also referred to as non-coated catheters, represent the standard design for intermittent urinary catheterization. The technologies include X-ray, magnetic resonance angiography (MRA), and computed tomography (CT), and the applications cover coronary, endovascular, neurological, oncology, and other procedures. They are used by end-users such as hospitals, ambulatory surgical centers, cardiac centers, brain centers, specialty clinics, and others.
The angiographic catheters market consists of sales of catheter shafts, tips, lumens, connectors, and balloons. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Angiographic Catheters Market Characteristics
3. Angiographic Catheters Market Supply Chain Analysis
4. Global Angiographic Catheters Market Trends and Strategies
5. Angiographic Catheters Market Analysis of End Use Industries
7. Global Angiographic Catheters Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Angiographic Catheters Total Addressable Market (TAM) Analysis for the Market
9. Angiographic Catheters Market Segmentation
10. Angiographic Catheters Market Regional and Country Analysis
11. Asia-Pacific Angiographic Catheters Market
12. China Angiographic Catheters Market
13. India Angiographic Catheters Market
14. Japan Angiographic Catheters Market
15. Australia Angiographic Catheters Market
16. Indonesia Angiographic Catheters Market
17. South Korea Angiographic Catheters Market
18. Taiwan Angiographic Catheters Market
19. South East Asia Angiographic Catheters Market
20. Western Europe Angiographic Catheters Market
21. UK Angiographic Catheters Market
22. Germany Angiographic Catheters Market
23. France Angiographic Catheters Market
24. Italy Angiographic Catheters Market
25. Spain Angiographic Catheters Market
26. Eastern Europe Angiographic Catheters Market
27. Russia Angiographic Catheters Market
28. North America Angiographic Catheters Market
29. USA Angiographic Catheters Market
30. Canada Angiographic Catheters Market
31. South America Angiographic Catheters Market
32. Brazil Angiographic Catheters Market
33. Middle East Angiographic Catheters Market
34. Africa Angiographic Catheters Market
36. Angiographic Catheters Market Competitive Landscape and Company Profiles
37. Angiographic Catheters Market Other Major and Innovative Companies
40. Angiographic Catheters Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Angiographic Catheters Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses angiographic catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for angiographic catheters? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The angiographic catheters market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Conventional Catheters; Drug Eluting Balloon Catheters; Cutting Balloon Catheters; Scoring Balloon Catheters2) By Technology: X-Ray; Magnetic Resonance Angiography (MRA); Computed Tomography (CT)
3) By Application: Coronary; Endovascular; Neurology; Oncology; Other Applications
4) By End User: Hospital; Ambulatory Surgical Centers; Cardiac Centers; Brain Centers; Specialty Clinics; Other End Users
Subsegments:
1) By Conventional Catheters: Diagnostic Catheters; Guiding Catheters; Balloon Catheters; Drug Eluting Balloon Catheters2) By Drug Eluting Balloon Catheters: Paclitaxel-Eluting Balloons; Sirolimus-Eluting Balloons
3) By Cutting Balloon Catheters: Standard Cutting Balloons; Specialty Cutting Balloons
4) By Scoring Balloon Catheters: Semi-Compliant Scoring Balloons; Non-Compliant Scoring Balloons
Companies Mentioned: Abbott Laboratories; Medtronic plc; Koninklijke Philips N.V.; Becton Dickinson and Company; Boston Scientific Corporation; B. Braun Melsungen AG; Terumo Corporation; Nipro Corporation; Cook Medical Inc.; Teleflex Incorporated; BIOTRONIK SE & Co. KG; Lepu Medical Technology (Beijing) Co Ltd.; Merit Medical Systems Inc.; Cordis Corporation; MicroPort Scientific Corporation; Asahi Intecc Co Ltd.; AngioDynamics Inc.; Biosensors International Group Ltd.; Alvimedica Medical Technologies; BrosMed Medical Co Ltd.; iVascular SLU; Reva Medical Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Angiographic Catheters market report include:- Abbott Laboratories
- Medtronic plc
- Koninklijke Philips N.V.
- Becton Dickinson and Company
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Terumo Corporation
- Nipro Corporation
- Cook Medical Inc.
- Teleflex Incorporated
- BIOTRONIK SE & Co. KG
- Lepu Medical Technology (Beijing) Co Ltd.
- Merit Medical Systems Inc.
- Cordis Corporation
- MicroPort Scientific Corporation
- Asahi Intecc Co Ltd.
- AngioDynamics Inc.
- Biosensors International Group Ltd.
- Alvimedica Medical Technologies
- BrosMed Medical Co Ltd.
- iVascular SLU
- Reva Medical Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.55 Billion |
| Forecasted Market Value ( USD | $ 2.21 Billion |
| Compound Annual Growth Rate | 9.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
